HomeAZN • NASDAQ
add
AstraZeneca plc
Previous close
$85.89
Day range
$85.86 - $86.88
Year range
$60.48 - $86.88
Market cap
266.50B USD
Avg Volume
4.88M
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 12.94B | 13.33% |
Operating expense | 7.87B | 12.44% |
Net income | 1.93B | 6.00% |
Net profit margin | 14.89 | -6.53% |
Earnings per share | 0.99 | -53.95% |
EBITDA | 4.15B | 12.76% |
Effective tax rate | 19.57% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.08B | 21.75% |
Total assets | 104.34B | 8.08% |
Total liabilities | 64.74B | 9.50% |
Total equity | 39.60B | — |
Shares outstanding | 1.55B | — |
Price to book | 3.37 | — |
Return on assets | 7.02% | — |
Return on capital | 9.97% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 1.93B | 6.00% |
Cash from operations | 3.08B | 79.57% |
Cash from investing | -2.87B | -452.31% |
Cash from financing | -1.22B | 19.55% |
Net change in cash | -1.02B | -184.31% |
Free cash flow | 2.05B | 52.92% |
About
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden and Gaithersburg in Maryland, U.S.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Throughout the twentieth century, it grew into the largest pharmaceutical company in Sweden. Wikipedia
Founded
Apr 6, 1999
Headquarters
Website
Employees
89,900